Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Tianyin Pharmaceutical Co Inc Announces Auditor Change Updates


Tuesday, 15 Oct 2013 12:23am EDT 

Tianyin Pharmaceutical Co Inc announced that as of October 8, 2013, the Audit Committee and the Board of Directors of TPI (the Company) both unanimously approved the termination of the Company's independent auditor, Patrizio and Zhao LLC (P&Z), due to the fact that P&Z agreed to a cease-and-desist order and prohibition from practicing before the Securities and Exchange Commission (the SEC) on September 30, 2013, with the right to apply for reinstatement after three years. engagement with P&Z on October 8, 2013, there were no: (1) disagreements with P&Z on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedure, which disagreements, if not resolved to their satisfaction, would have caused them to make reference in connection with their opinion to the subject matter of the disagreements, or (2) reportable events. Since P&Z is barred from practicing before the SEC, financial statements for a period previously audited by P&Z and required to be included in a filing made by the Company after September 30, 2013 will have to be re-audited by a firm that is registered with the PCAOB. Currently, the Company is evaluating options to appoint a new independent registered public accounting firm to replace P&Z. 

Company Quote

0.45
1.0E-4 +0.02%
1 Apr 2015